Bruce & Co., Inc. Caribou Biosciences, Inc. Transaction History

Bruce & Co., Inc.

$236 Million
Q2 2025

A detailed history of Bruce & Co., Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Bruce & Co., Inc. holds 250,000 shares of CRBU stock, worth $725,000. This represents 0.13% of its overall portfolio holdings.

Number of Shares

250,000

Previous 250,000 -0.0%

Holding current value

$725,000

Previous $227,000 38.77%

% of portfolio

0.13%

Previous 0.1%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$1.59 - $2.79 $79,500 - $139,500	-50,000 Reduced 16.67%	250,000 $397,000
Q2 2024 Aug 09, 2024	BUY	$1.62 - $5.05 $162,000 - $505,000	100,000 Added 50.0%	300,000 $491,000
Q2 2023 Aug 08, 2023	BUY	$4.04 - $5.47 $404,000 - $547,000	100,000 Added 100.0%	200,000 $850,000
Q1 2023 May 12, 2023	BUY	$4.3 - $7.78 $430,000 - $778,000	100,000 New	100,000 $531,000

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

43.6M

Call Options Held

25K

Put Options Held

53.2K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $176M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.

Account